← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cmtx Biotech, Inc.
Kings Park, NY
$2,601,558
Total funding
4
Grants
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,601,558 · 4
By mechanism
R42$1,314,098 · 1
R41$972,460 · 2
U34$315,000 · 1
Investigators at Cmtx Biotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome$887,354
R42 · FY2025 · HL
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome$426,744
R42 · FY2023 · HL
Novel Small Molecule Drug Candidate for the Prevention of Bronchopulmonary Dysplasia$376,752
R41 · FY2023 · HD
Repurposing Incyclinide for the Treatment of Hospitalized COVID-19 Patients$315,000
U34 · FY2021 · TR
A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung Injury$299,993
R41 · FY2024 · AI
A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung Injury$295,715
R41 · FY2025 · AI